AstraZeneca may have provided incomplete efficacy data from the latest COVID-19 trials: US NIAID
The US National Institute of Allergy and Infectious Diseases (NIAID) has expressed concerns that British drugmaker may have provided incomplete ...
The US National Institute of Allergy and Infectious Diseases (NIAID) has expressed concerns that British drugmaker may have provided incomplete ...